Analysts expect Beam Therapeutics Inc. to report revenue of 8.50 M for Q3 26, against a range of 8.05 M to 8.95 M. The most recent reported quarter, Q2 26, came in at 490,000.00, a 97.2% miss against the 17.25 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 14.27 M | 30.07 M | 7.47 M | 8.47 M | 9.70 M | 114.11 M | 31.74 M | 490,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 14.77 M | 17.32 M | 15.71 M | 13.99 M | 11.49 M | 13.26 M | 11.24 M | 18.96 M | 8.95 M | 11.29 M | 15.95 M | 14.47 M | 31.14 M | 63.55 M | 10.80 M | 14.82 M | ||||||||||
| Low Estimate | 13.69 M | 14.70 M | 13.11 M | 13.01 M | 10.63 M | 11.58 M | 9.71 M | 15.53 M | 8.05 M | 9.87 M | 13.83 M | 13.41 M | 27.78 M | 52.45 M | 9.40 M | 13.44 M | ||||||||||
| Consensus Estimate | 14.23 M | 16.01 M | 14.41 M | 13.50 M | 11.06 M | 12.42 M | 10.47 M | 17.25 M | 8.50 M | 10.58 M | 14.89 M | 13.94 M | 29.46 M | 58.00 M | 10.10 M | 14.13 M |
Analysts expect Beam Therapeutics Inc. to report earnings per share of -1.22 for Q3 26, against a range of -1.27 to -1.17. The most recent reported quarter, Q2 26, came in at -1.18, a 11.3% miss against the -1.06 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.17 | -1.09 | -1.24 | -1.00 | -1.10 | 2.33 | -0.91 | -1.18 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.14 | -1.13 | -1.19 | -1.08 | -1.02 | -0.99 | -0.91 | -1.01 | -1.17 | -1.17 | -1.08 | -1.19 | -1.20 | -0.69 | -1.51 | -1.24 | ||||||||||
| Low Estimate | -1.32 | -1.23 | -1.29 | -1.28 | -1.18 | -1.11 | -1.03 | -1.11 | -1.27 | -1.25 | -1.20 | -1.45 | -1.42 | -0.77 | -1.65 | -1.32 | ||||||||||
| Consensus Estimate | -1.23 | -1.18 | -1.24 | -1.18 | -1.10 | -1.05 | -0.97 | -1.06 | -1.22 | -1.21 | -1.14 | -1.32 | -1.31 | -0.73 | -1.58 | -1.28 |
Pull Wall Street consensus for Beam Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BEAM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BEAM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BEAM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();